52 studies found for:    Pamidronate
Show Display Options
Rank Status Study
1 Completed A Pilot Trial of IV Pamidronate for Low Back Pain
Condition: Chronic Low Back Pain
Intervention: Drug: Pamidronate
2 Unknown  A Pilot Trial of Intravenous (IV) Pamidronate for Low Back Pain
Condition: Low Back Pain
Intervention: Drug: pamidronate
3 Completed Efficacy of Pamidronate in the Treatment of Bone Loss Associated With Liver Transplant
Condition: Bone Disease, Metabolic
Interventions: Drug: Disodium pamidronate;   Drug: Placebo
4 Active, not recruiting Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide;   Drug: Zometa
5 Completed Combination Bisphosphonate and Anti-Angiogenesis Therapy With Pamidronate and Thalidomide
Condition: Multiple Myeloma
Interventions: Drug: Pamidronate;   Drug: Thalidomide
6 Recruiting Golimumab Versus Pamidronate for the Treatment of Axial Spondyloarthropathy: a 48-week Trial
Condition: Spondyloarthropathy
Interventions: Drug: golimumab;   Drug: Pamidronate
7 Completed Arsenic Trioxide and Pamidronate in Treating Patients With Advanced Solid Tumors or Multiple Myeloma
Conditions: Refractory Multiple Myeloma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: pamidronate disodium;   Drug: arsenic trioxide;   Other: laboratory biomarker analysis;   Other: pharmacological study
8 Completed Pamidronate Administration in Breast Cancer Patients With Bone Metastases
Conditions: Breast Cancer;   Neoplasm Metastasis
Intervention: Drug: Pamidronate
9 Recruiting Efficiency and Safety Study of Pamidronate in Inflammatory Back Pain Due to Degenerative Disk Disease
Conditions: Intervertebral Disc Degeneration;   Modic I Discopathy;   Back Pain;   Low Back Pain;   Magnetic Resonance Imaging (MRI)
Interventions: Drug: Pamidronate;   Other: Placebo
10 Withdrawn Study of Pamidronate for the Prevention of Heterotopic Ossification
Condition: Heterotopic Ossification
Intervention: Drug: Pamidronate (AREDIA)
11 Completed A Prospective, Multicentre, Open-label Randomised Controlled Study to Investigate the Effectiveness of Pamidronate in the Prevention of Bone Loss in de Novo Renal Transplant Patients.
Condition: Bone Loss
Intervention: Drug: Pamidronate
12 Completed Pamidronate, Vitamin D, and Calcium for the Bone Disease of Kidney and Heart Transplantation
Condition: Transplant Bone Disease
Interventions: Drug: Pamidronate;   Drug: vitamin D;   Drug: calcium supplement
13 Active, not recruiting Pamidronate to Treat Osteogenesis Imperfecta in Children
Condition: Osteogenesis Imperfecta
Intervention: Drug: Pamidronate (Aredia)
14 Active, not recruiting Combination Chemotherapy, Peripheral Stem Cell Transplantation, Biological Therapy, Pamidronate and Thalidomide in Treating Patients With Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Biological: recombinant interferon alfa;   Drug: busulfan;   Drug: cyclophosphamide;   Drug: melphalan;   Drug: pamidronate disodium;   Drug: thalidomide;   Procedure: peripheral blood stem cell transplantation
15 Unknown  Comparison of Pamidronate With Zoledronic Acid for Transplant Related Bone Loss Prevention
Conditions: Osteopenia;   Heart Transplantation;   Lung Transplantation
Intervention: Drug: zoledronic acid vs pamidronate
16 Unknown  Effect of Local Pamidronate in Preventing Bone Loss After Total Hip Arthroplasty
Conditions: Arthroplasty;   Mineral Density
Intervention: Drug: pamidronate
17 Completed Prevention of Post Operative Bone Loss in Children
Conditions: Osteoporosis;   Cerebral Palsy;   Spina Bifida;   Osteopenia;   Osteogenesis Imperfecta
Interventions: Drug: pamidronate;   Other: saline
18 Completed Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
Condition: Multiple Myeloma
Intervention: Drug: pamidronate
19 Active, not recruiting Samarium Sm 153 Lexidronam Pentasodium Combined With Zoledronic Acid or Pamidronate in Treating Patients With Relapsed or Refractory Multiple Myeloma and Bone Pain
Conditions: Multiple Myeloma and Plasma Cell Neoplasm;   Pain
Interventions: Drug: Pamidronate;   Drug: Zoledronic acid;   Radiation: Sm 153 lexidronam
20 Terminated Prevention of Steroid-Induced Osteoporosis in Children
Condition: Osteoporosis
Intervention: Drug: Pamidronate

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years